Stem cell treatments maker Mesoblast’s shares have taken a hit after the company said its $US50 million partnership with biotech giant Novartis has fizzled out.
Brisbane Times – Business
Business
More in:Business
Business
ABC executive behind Antoinette Lattouf sacking departs
The decision to sack Lattouf has plagued the broadcaster for a year and will be ...
Business
WA Government stumps up $175,000 for rare earths research
The WA Government has stumped up $175,000 for research into the extraction of rare earths. ...
Business
Melbourne-Sydney flights jump in price after competition collapse
Flying domestically has become cheaper, but not between Melbourne and Sydney. Business / Consumer affairs ...